FRE
Firebrick Pharma Limited
Save
10.40M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Drug Manufacturers - General
Industry
Firebrick Pharma Limited engages in the development and commercialization of nasal spray treatment for the common cold under the Nasodine name in Australia.
Similar securities
Based on sector and market capitalization
Report issue